These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation. Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190 [TBL] [Abstract][Full Text] [Related]
4. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome. Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597 [TBL] [Abstract][Full Text] [Related]
5. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil. Matzenbacher Bittar C; de Araújo Rocha YM; Vieira IA; Rosset C; Andreis TF; Sartor ITS; Artigalás O; Netto CBO; Alemar B; Macedo GS; Ashton-Prolla P PLoS One; 2021; 16(9):e0251639. PubMed ID: 34529667 [TBL] [Abstract][Full Text] [Related]
12. Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation. Andrade KC; Santiago KM; Fortes FP; Mambelli LI; Nóbrega AF; Achatz MI Genet Mol Biol; 2016 May; 39(2):199-202. PubMed ID: 27223487 [TBL] [Abstract][Full Text] [Related]
13. MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers. Bandeira IC; Vieira IA; Andreis TF; Brussa Reis L; Macedo GS; Vianna FSL; Santos-Silva P; Palmero EI; Galvão HCR; Ramos CRN; Santiago KM; Achatz MI; da Costa AABA; Ashton-Prolla P Cancer Genet; 2020 Jan; 240():54-58. PubMed ID: 31778928 [TBL] [Abstract][Full Text] [Related]
14. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome. Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648 [TBL] [Abstract][Full Text] [Related]
15. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1. Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580 [TBL] [Abstract][Full Text] [Related]
16. Number of rare germline CNVs and TP53 mutation types. Silva AG; Achatz IM; Krepischi AC; Pearson PL; Rosenberg C Orphanet J Rare Dis; 2012 Dec; 7():101. PubMed ID: 23259501 [TBL] [Abstract][Full Text] [Related]
18. The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancer. Giacomazzi J; Correia RL; Palmero EI; Gaspar JF; Almeida M; Portela C; Camey SA; Monteiro A; Pinheiro M; Peixoto A; Teixeira MR; Reis RM; Ashton-Prolla P Breast J; 2014; 20(5):534-6. PubMed ID: 25052705 [TBL] [Abstract][Full Text] [Related]
19. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers. Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis. Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]